Evidence map›Paper›PMID 29483513›Full record

ArticleNature communications2018

Clonally diverse CD38

Zhongfang Wang, Lingyan Zhu, Thi H O Nguyen, Yanmin Wan, Sneha Sant, Sergio M Quiñones-Parra, Jeremy Chase Crawford, Auda A Eltahla, Simone Rizzetto, Rowena A Bull and 20 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 130 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Assessing CD8Clinical & translational immunology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. CD8Science advances · 2025
    Article
  14. Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  15. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 6 institutions in 3 countries.

Zhongfang WangShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Lingyan ZhuShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Thi H O NguyenDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Yanmin WanShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Sneha SantDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Sergio M Quiñones-ParraDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Jeremy Chase CrawfordDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.ORCID http://orcid.org/0000-0003-4096-6048
Auda A EltahlaSchool of Medical Sciences and The Kirby Institute, UNSW Sydney, Sydney, NSW, 2052, Australia.
Simone RizzettoSchool of Medical Sciences and The Kirby Institute, UNSW Sydney, Sydney, NSW, 2052, Australia.
Rowena A BullSchool of Medical Sciences and The Kirby Institute, UNSW Sydney, Sydney, NSW, 2052, Australia.
Chenli QiuShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Marios KoutsakosDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
E Bridie ClemensDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Liyen LohDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Tianyue ChenShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Lu LiuShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Pengxing CaoSchool of Mathematics and Statistics, University of Melbourne, Parkville, VIC, 3010, Australia.
Yanqin RenShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Lukasz KedzierskiDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Tom KotsimbosDepartment of Respiratory Medicine, Alfred Hospital Health and Department Medicine, Monash University, 99 Commercial Road, Melbourne, VIC, 3004, Australia.
James M McCawSchool of Mathematics and Statistics, University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-2452-3098
Nicole L La GrutaDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Stephen J TurnerDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Allen C ChengInfection Prevention and Healthcare Epidemiology Unit, Alfred Health and School of Public Health and Preventive Medicine, 99 Commercial Road, Melbourne, VIC, 3004, Australia.
Fabio LucianiSchool of Medical Sciences and The Kirby Institute, UNSW Sydney, Sydney, NSW, 2052, Australia.
Xiaoyan ZhangShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China.
Peter C DohertyDepartment of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, 3010, Australia.
Paul G ThomasDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Jianqing XuShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China. xujianqing@shphc.org.cn.ORCID http://orcid.org/0000-0003-0896-9273
Katherine KedzierskaShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, 201508, Shangai, China. kkedz@unimelb.edu.au.
The University of Melbourne · AUShanghai Medical College of Fudan University · CNUNSW Sydney · AUSt. Jude Children's Research Hospital · USAlfred Health · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe influenza A virus (IAV) infection is associated with immune dysfunction. Here, we show circulating CD8

Indexed as

ADP-ribosyl Cyclase 1CD8-Positive T-LymphocytesClonal Selection, Antigen-MediatedCohort StudiesCritical IllnessGene Expression RegulationHLA-DR AntigensHospitalizationHumansInfluenza A Virus, H7N9 SubtypeInfluenza, HumanLymphocyte ActivationMembrane GlycoproteinsProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-Cell, alpha-betaSurvival AnalysisADP-ribosyl Cyclase 1CD38 protein, humanHLA-DR AntigensMembrane GlycoproteinsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID29483513
PMCPMC5827521
OpenAlexW2806868583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.